Related Experiment Video
Updated: Dec 29, 2025

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
Alcohol effects on hepatic lipid metabolism
Sookyoung Jeon1, Rotonya Carr2
1Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA.
Alcoholic liver disease (ALD) involves impaired lipid metabolism in the liver, progressing from fatty liver to cirrhosis. Understanding these metabolic changes is key to addressing ALD progression and its severe health impacts.
Area of Science:
- Hepatology
- Metabolic Research
- Toxicology
Background:
- Alcoholic liver disease (ALD) is a leading cause of chronic liver disease globally, characterized by progressive liver damage.
- ALD pathogenesis involves a spectrum from simple hepatic steatosis to alcoholic steatohepatitis, fibrosis, and cirrhosis.
- Hepatic steatosis severity is a critical determinant for the progression to advanced stages of ALD.
Purpose of the Study:
- To comprehensively review the disruptions in hepatic lipid metabolism caused by alcohol consumption.
- To elucidate the mechanisms underlying alcohol-induced hepatic lipid accumulation.
- To explore the roles of genetics and bioactive lipids in ALD pathogenesis.
Main Methods:
- Literature review of studies investigating alcohol's impact on liver lipid metabolism.
- Analysis of pathways including lipid uptake, synthesis, oxidation, and export.
- Examination of lipid droplet dynamics and emerging genetic and bioactive lipid data.
Main Results:
- Alcohol significantly alters hepatic lipid metabolism through multiple pathways.
- Disturbances in lipid uptake, de novo synthesis, fatty acid oxidation, and export contribute to fat accumulation.
- Lipid droplet formation, catabolism, genetics, and bioactive lipids are increasingly recognized in alcohol-induced hepatic steatosis.
Conclusions:
- Alcohol-induced hepatic lipid metabolism dysregulation is central to ALD development and progression.
- Targeting these metabolic pathways, including genetic and bioactive lipid influences, offers potential therapeutic strategies for ALD.
- Further research into the complex interplay of factors driving hepatic lipid accumulation is crucial for effective ALD management.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents

